Skip to content

equity

No borders, no nations, no user charges

It was recently proposed that, here in the UK, foreigners should start having to pay towards their health care because of the apparent budgetary pressure from ‘health tourists’. Let’s be clear upfront; this isn’t a problem. If you believe the media, ‘health tourism’… Read More »No borders, no nations, no user charges

Economics of personalised medicine: an introduction

Personalised medicine appears to be an inevitable future of health care, and economists aren’t ready for it. It has various monikers and related concepts including precision medicine, stratified medicine, pharmacogenomics, pharmacogenetics and predictive medicine. But, whatever you call it, it means big… Read More »Economics of personalised medicine: an introduction

The potential of the super QALY to reconcile the key contentions in health economics

Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying this for a.very.long.time. Despite this, as… Read More »The potential of the super QALY to reconcile the key contentions in health economics